{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T09:29:54Z","timestamp":1720949394975},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/dad.0b013e31825aa334","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T22:59:46Z","timestamp":1340319586000},"page":"45-49","source":"Crossref","is-referenced-by-count":4,"title":["Expression of Matrix Metalloproteinase-13 and Ki-67 in Nonmelanoma Skin Cancer in Xeroderma Pigmentosum and Non-xeroderma Pigmentosum"],"prefix":"10.1097","volume":"35","author":[{"given":"Amira K.","family":"El-Hawary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Khater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheir","family":"Abdelgaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0041-1733109","article-title":". Squamous cell carcinoma of face with xeroderma pigmentosaa case report.","volume":"26","author":"Pathy","year":"2005","journal-title":"Indian J Med Oncol"},{"key":"R2-7-20210202","first-page":"78","article-title":"Xeroderma pigmentosaa disfiguring disease.","volume":"4","author":"Eugene","year":"2006","journal-title":"Kathmandu Univ Med J"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2334\/josnusd.52.505","article-title":". Trichilemmal carcinoma associated with xeroderma pigmentosa: report of a rare case.","volume":"52","author":"Mane","year":"2010","journal-title":"J Oral Sci"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archderm.1987.01660260111026","article-title":"Xeroderma pigmentosum.","volume":"23","author":"Kraemer","year":"1987","journal-title":"Arch Dermatol"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0151-9638(04)93538-7","article-title":". Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients.","volume":"131","author":"Moussaid","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00000372-199608000-00004","article-title":". Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas.","volume":"18","author":"Mansoor","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.1995.tb02748.x","article-title":". Prognostic value of Ki-67 antigen expression in basal cell carcinoma.","volume":"133","author":"Healy","year":"1995","journal-title":"Br J Dermatol"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2559.2007.02885.x","article-title":". Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.","volume":"51","author":"OGrady","year":"2007","journal-title":"Histopathology"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0625.2003.120201.x","article-title":"Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.","volume":"12","author":"Kerkela","year":"2003","journal-title":"Exp Dermatol"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.10329","article-title":"Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.","volume":"99","author":"Vihinen","year":"2002","journal-title":"Int J Cancer"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12319441","article-title":". Human collagenase-3 is expressed in malignant squamous epithelium of the skin.","volume":"109","author":"Airola","year":"1997","journal-title":"J Invest Dermatol"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4321\/S0365-66912004000600006","article-title":". Collagenase-3 (MMP-13) expression in epithelial cancers of the eyelids.","volume":"79","author":"Alvarez Suarez","year":"2004","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/sj.onc.1207678","article-title":". Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.","volume":"23","author":"Ala-aho","year":"2004","journal-title":"Oncogene"},{"key":"R14-7-20210202","first-page":"667","article-title":"Practical points on the microscopic grading of carcinoma.","volume":"32","author":"Broders","year":"1932","journal-title":"NY State J Med"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/29.10.7028859","article-title":"Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.","volume":"29","author":"Wood","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"R16-7-20210202","first-page":"2167","article-title":". Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis.","volume":"27","author":"Papadopoulosi","year":"2007","journal-title":"Anticancer Res"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3747\/co.v17i3.479","article-title":"Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum.","volume":"17","author":"Wei","year":"2010","journal-title":"Curr Oncol"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.joms.2007.09.026","article-title":". Xeroderma pigmentosum: a retrospective case series in Zimbabwe.","volume":"67","author":"Chidzonga","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2009.130","article-title":". Stromal expression of MMP-13 is required for melanoma invasion and metastasis.","volume":"129","author":"Zigrino","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R21-7-20210202","first-page":"499","article-title":". Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.","volume":"15","author":"Johansson","year":"1997","journal-title":"Am J Pathol"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer.","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/07853899909019260","article-title":"Matrix metalloproteinases and their inhibitors in tumour growth and invasion.","volume":"31","author":"Kahari","year":"1999","journal-title":"Ann Med"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2009.01401.x","article-title":". Xeroderma pigmentosum skin: an immune privilege site for tumor development.","volume":"37","author":"Abid","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1044-579X(02)00015-9","article-title":"Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells.","volume":"12","author":"Seo","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"R26-7-20210202","first-page":"471","article-title":". Ki-67 index and skin carcinomas with skull base invasion: a case-control study.","volume":"3","author":"Cernea","year":"2005","journal-title":"Cancer Ther"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1365-4632.2009.04382.x","article-title":". Immunohistochemical prognostic criteria in xeroderma pigmentosum.","volume":"49","author":"Karakok","year":"2010","journal-title":"Int J Dermatol"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2184.2003.00282.x","article-title":"Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index.","volume":"36","author":"Dissanayake","year":"2003","journal-title":"Cell Prolif"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.bjc.6604967","article-title":". Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.","volume":"100","author":"Torres-Rendon","year":"2009","journal-title":"Br J Cancer"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-201302000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:03:44Z","timestamp":1714089824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201302000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31825aa334","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}